| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:1802.)
© 2000 American Heart Association, Inc.
Original Contributions |
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction
Results From the Cooperative Cardiovascular Project
From the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn (L.M.B., J.H.L., M.J.R., H.M.K.); Neurology Service, VA Connecticut Healthcare System, West Haven, Conn (L.M.B.); Yale Stroke Program, Department of Neurology (L.M.B., J.H.L.); Section of Chronic Disease Epidemiology, School of Epidemiology and Public Health (L.M.B., H.M.K.), and Department of Cardiology (H.M.K.), Yale University School of Medicine, New Haven, Conn; Qualidigm (L.M.B., Y.W., M.J.R., H.M.K.), Middletown, Conn; and Meyers Primary Care Institute, Fallon Healthcare System and University of Massachusetts Medical School, Worcester (J.H.G.).
Correspondence to Lawrence M. Brass, MD, Yale Stroke Program, Department of Neurology, LCI-700, Yale University School of Medicine, 15 York St, PO Box 208018, New Haven, CT 06520-8018. E-mail Lawrence.Brass{at}yale.edu
Background and Purpose—Intracranial hemorrhage is a serious complication of thrombolytic therapy for acute myocardial infarction, especially among the elderly, but little information exists on estimating risk. Better estimation of risk in individual patients may allow for withholding or using alternate therapies among those at highest risk.
Methods—To quantify the risk and identify predictors of intracranial hemorrhage associated with thrombolytic therapy, we performed a retrospective cohort study using data from medical charts. The study involved nearly all acute-care hospitals in the United States. All Medicare patients discharged with a principal diagnosis of acute myocardial infarction during a 9-month period in 1994 to 1995 were included. The main outcome measure was intracranial hemorrhage among those treated with thrombolytic therapy.
Results—The rate of intracranial hemorrhage was 1.43%
(455 of 31 732). In a logistic model, age 
75 years, female, black
race, prior stroke, blood pressure 160 mm Hg, tissue
plasminogen activator (versus other
thrombolytic agent), excessive anticoagulation
(international normalized ratio 4 or prothrombin time 24), and
below median weight (
65 kg for women; 80 kg for men) were
independent predictors. A risk stratification scale was developed on
the basis of these factors: with none or 1 of the factors (n=6651), the
rate of intracranial hemorrhage was 0.69%; with 2 factors
(n=10 509), 1.02%; with 3 factors (n=9074), 1.63%; with 4 factors
(n=4298), 2.49%; and with 5 factors (n=1071), 4.11%
(Mantel-Haenszel; P<0.001).
Conclusions—The rate of intracranial hemorrhage in older patients after treatment with thrombolytic therapy exceeds 1%. Readily available factors can identify elderly patients with acute myocardial infarction at high and low risk for intracranial hemorrhage associated with thrombolytic therapy.
Key Words: intracranial hemorrhage • myocardial infarction • risk factors • thrombolytic therapy
This article has been cited by other articles:
 |
|
 |
|
  E. B. Kaya, U. Kocabas, K. Aytemir, and L. Tokgozoglu Successful fibrinolytic treatment in an old patient with acute aortic prosthetic thrombosis Eur J Echocardiogr, July 1, 2008; 9(4): 581 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Goodman, V. Menon, C. P. Cannon, G. Steg, E. M. Ohman, and R. A. Harrington Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 708S - 775S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations Stroke, September 1, 2007; 38(9): 2612 - 2618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Mega, D. A. Morrow, E. Ostor, M. Dorobantu, J. Qin, E. M. Antman, and E. Braunwald Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction Circulation, June 5, 2007; 115(22): 2822 - 2828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al. Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology Circulation, May 15, 2007; 115(19): 2570 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mehta, R. M. Califf, J. Garg, H. D. White, F. Van de Werf, P. W. Armstrong, K. S. Pieper, E. J. Topol, and C. B. Granger The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction Eur. Heart J., February 2, 2007; 28(4): 415 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Huynh, J. O'Loughlin, L. Joseph, E. Schampaert, S. Rinfret, M. Afilalo, S. Kouz, B. Cantin, M. Nguyen, M. J. Eisenberg, et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study Can. Med. Assoc. J., December 5, 2006; 175(12): 1527 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kent, H. P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window? Stroke, December 1, 2006; 37(12): 2963 - 2969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Koennecke Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications Neurology, January 24, 2006; 66(2): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mehta, C. B. Granger, K. P. Alexander, E. Bossone, H. D. White, and M. H. Sketch Jr Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and risks J. Am. Coll. Cardiol., February 15, 2005; 45(4): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Stenestrand and L. Wallentin Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment-Elevation Myocardial Infarction: One-Year Follow-up of a Large Prospective Cohort Arch Intern Med, April 28, 2003; 163(8): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Estess and E J Topol Fibrinolytic treatment for elderly patients with acute myocardial infarction Heart, April 1, 2002; 87(4): 308 - 311. [Full Text] [PDF]
|
|